Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 1
2024 4
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity, safety, and reactogenicity of concomitant administration of the novavax vaccine against Omicron XBB.1.5 (NVX-CoV2601) and a 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: A randomised, double-blind, placebo-controlled, non-inferiority trial.
Jorda A, Prager M, Pracher L, Haselwanter P, Jackwerth M, Al Jalali V, Yildiz E, Leutzendorff A, Weber M, Yourieva S, Kammerer P, Pecho T, Decaminada A, Ederer L, Wiedermann U, Weseslindtner L, Redlberger-Fritz M, Bergmann F, Zeitlinger M. Jorda A, et al. Among authors: haselwanter p. J Infect. 2025 Feb;90(2):106405. doi: 10.1016/j.jinf.2024.106405. Epub 2025 Jan 3. J Infect. 2025. PMID: 39756693 Free article. Clinical Trial.
Tissue pharmacokinetics of antifungal drugs: a review.
Bergmann F, Prager M, Pracher L, Jorda A, Haselwanter P, Zeitlinger M. Bergmann F, et al. Among authors: haselwanter p. Int J Antimicrob Agents. 2026 Feb 12;67(5):107743. doi: 10.1016/j.ijantimicag.2026.107743. Online ahead of print. Int J Antimicrob Agents. 2026. PMID: 41690638 Free article. Review.
Presence of cholestasis and its impact on survival in SARS-CoV-2 associated acute respiratory distress syndrome.
Schneeweiss-Gleixner M, Krenn K, Petter M, Haselwanter P, Kraft F, Adam L, Semmler G, Hartl L, Halilbasic E, Buchtele N, Krall C, Staudinger T, Zauner C, Trauner M, Stättermayer AF. Schneeweiss-Gleixner M, et al. Among authors: haselwanter p. Sci Rep. 2024 Oct 8;14(1):23377. doi: 10.1038/s41598-024-73948-x. Sci Rep. 2024. PMID: 39379494 Free PMC article.
13 results